You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
Biomarkers Being Explored Within Gastric Cancer Landscape
The potential options for gastric cancer are rapidly evolving based on new research into existing and emerging biomarkers. Learn about the current unmet need in gastric and gastroesophageal junction (GEJ) cancer, and how biomarkers have the potential to advance care for these patients.
After his own cancer diagnosis, Dr. Mark Lewis, Intermountain Healthcare Director of GI Oncology, has made advancing cancer research a personal matter. Hear his thoughts on how and why the gastric and GEJ cancer landscape needs to evolve and the biomarkers that are driving new research.
074-0593-PM 11/22 MAT-US-NON-2022-01013
Get only the email alerts you want.
For media inquiries and reporter requests, please click here to fill out a request form.
Our communications team will respond to verified media requests within 24-48 hours as appropriate.
If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.